10 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Mutanome Engineered RNA Immuno-Therapy (MERIT)
Date du début: 1 juin 2013, Date de fin: 30 nov. 2017,
The Mutanome Engineered RNA Immuno-Therapy (MERIT) project aims to clinically translate and industrially validate a pioneering RNA-based immunotherapy approach to target the individual tumour antigen signature. MERIT focuses on previous inventions, fits into the overall business and innovation needs of the partners, and addresses triple-negative breast cancer patients with high medical need. The M ...
Voir le projet
5
Participants partenaires
TERMINÉ
Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects (decent AID)
Date du début: 1 avr. 2013, Date de fin: 31 mars 2017,
Drug delivery systems are a matter of intensive scientific investigation and technological developments. They are necessary since many active pharmaceutical ingredients to be employed in therapy, diagnostics or vaccination cause serious side effects when distributed non-specifically. Without a drug delivery system, the active pharmaceutical ingredients may accumulate in healthy and sensitive tissu ...
Voir le projet
4
Participants partenaires
TERMINÉ
Tumor Infiltrating Myeloid Cell Compartment (TIMCC)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
"The ITN TIMCC brings together eight expert teams from different disciplines within Immunology, Genetics and Oncology, to provide substantive and methodological training in the analysis of the role of the Tumor Infiltrating Myeloid Cell Compartment (TIMCC) of the innate immune system. Leukocytes recruited to (pre)malignant tissues are mainly myeloid cells. They can either prevent or functionally c ...
Voir le projet
8
Participants partenaires
TERMINÉ
Development of RApid Point-of-Care test Platforms for Infectious Diseases (RAPP-ID)
Date du début: 1 avr. 2011, Date de fin: 30 sept. 2016,
RAPP-ID (“Development of RApid Point-of-Care test Platforms for Infectious Diseases”) will develop a Point-of-Care Test (POCT) for rapid (hospital
Voir le projet
20
Participants partenaires
TERMINÉ
Novel diagnostic bio-assays based on magnetic particles (BIOMAX)
Date du début: 1 févr. 2011, Date de fin: 31 janv. 2015,
Nanotechnology-based in-vitro diagnostics is set to solve several important problems in global healthcare. R&D in this field requires collaborations between experts from different scientific disciplines with a strong focus on the integration of bio-, nano- and microtechnologies. However, such personnel is still scarce. This BioMaX training-through-research network responds to the need for skilled ...
Voir le projet
7
Participants partenaires
TERMINÉ
Two Stage Rapid Biological Surveillance and Alarm System for Airborne Pathogenic Threats (TWOBIAS)
Date du début: 1 juil. 2010, Date de fin: 31 déc. 2013,
"The aim of this project is to develop a demonstrable, modular and “close-to-market” demonstrator of a stationary rapid reliable vehicle-portable Two Stage Rapid Biological Surveillance and Alarm System for Airborne Threats (TWOBIAS) with extremely low false alarm rates. TWOBIAS will provide reliable information to command control systems (CCS) and first responders within seconds, enhancing securi ...
Voir le projet
11
Participants partenaires
TERMINÉ
"Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system" (MOODINFLAME)
Date du début: 1 nov. 2008, Date de fin: 30 avr. 2013,
"Partners come from 10 European countries to achieve two main objectives: A) The further exploration of 3 animal models (the OBX rat, GS rat and NOD mouse) characterized by an activated immune response system (IRS), an abnormal tryptophan catabolism and a depressive-like behaviour to study the pathogenesis of inflammation-related mood disorders and the efficacy/working mechanism of anti-inflammat ...
Voir le projet
21
Participants partenaires
TERMINÉ
REvolutionary Approaches and Devices for Nucleic Acid Analysis (READNA)
Date du début: 1 juin 2008, Date de fin: 30 nov. 2012,
"The REvolutionary Approaches and Devices for Nucleic Acid analysis – READNA – consortium is composed of researchers from 10 academic institutions, 5 SMEs and 3 large companies. The goals of the READNA consortium are to revolutionize nucleic acid analysis methods, by 1) improving elements necessary to use the currently emerging generation of nucleic acid sequencers in a meaningful and accessible w ...
Voir le projet
20
Participants partenaires
TERMINÉ
Advanced affinity tools and technologies for high throughput studies of the human proteome (AffinityProteome)
Date du début: 1 mars 2009, Date de fin: 29 févr. 2012,
High specificity affinity reagents (‘binders’) are essential probes for proteome research, enabling the detection and localisation of multiple proteins in tissues and fluids in health and disease, through the application of binder-based technologies (affinity proteomics). This proposal links the high throughput production of quality-controlled, recombinant binding molecules of different types (ant ...
Voir le projet
10
Participants partenaires
TERMINÉ
European Genetic Disease Diagnostics (EURO-GENE-SCAN)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2011,
"Molecular techniques have become more efficient, increasingly precise and much cheaper, resulting in an unprecedented discovery rate of inherited disease genes. In areas such as primary immunodeficiencies (PID), muscle disorders, growth deficiencies, hearing/vision impairments and metabolic diseases, very large numbers of different genes have been found to carry mutations in diseases with heterog ...
Voir le projet